Mark David Linch

4.2k citations
67 papers · 2.9k · 2 hit papers · h-index 25

Impact in

Papers in

Mark David Linch

64 papers receiving 2.8k citations

Mark David Linch's Hit Papers

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder 2022 · 157 citations
1570+2+4Years since publication100200300400

Peers

Mark David Linch
Comparison fields: 5 of 122
  • Oncology 811
  • Cancer Research 311
  • Pulmonary and Respiratory Medicine 568
  • Surgery 770
  • Cell Biology 254
Replace Makoto Saegusa with:
Makoto Saegusa Japan
Baoqing Jia China
Zhi‐Yong Wu China
Ralph Markus Wirtz Germany
Ralph Fritsch Germany
Mu-Yan Cai China
Akimasa Hayashi Japan
JEFF EVANS United Kingdom
Claudia Hube‐Magg Germany
Pau Castel United States
Mark David Linch relative to Makoto Saegusa Japan Makoto Saegusa's profile →
Citations per field
00.5×2×2.8×
Makoto Saegusa · 1×
Citations per year

Countries citing papers authored by Mark David Linch

Since Specialization
Citations

This map shows the geographic impact of Mark David Linch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark David Linch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark David Linch more than expected).

Fields of papers citing papers by Mark David Linch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark David Linch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark David Linch. The network helps show where Mark David Linch may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark David Linch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark David Linch Line = papers co-authored together Mark David Linch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Hit paper breakdown →
2019457
2 2010377
3 2021187
4 2014185
5
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
Hit paper breakdown →
2022157
6 2019147
7 201794
8 200987
9 201383
10 201480
11 201172
12 202263
13 202063
14 201751
15 201351
16 201648
17 200646
18 202046
19 201843
20 202040

About Mark David Linch

Mark David Linch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 67 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Protein Kinase Regulation and GTPase Signaling (9 papers), Cancer Genomics and Diagnostics (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Urinary and Genital Oncology Studies (6 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Oncology (811 citations), Cancer Research (311 citations), Pulmonary and Respiratory Medicine (568 citations), Surgery (770 citations) and Cell Biology (254 citations). Mark David Linch has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Peter J. Parker, Carine Rossé, Angus J.M. Cameron, Katrina Boeckeler, Stéphanie Kermorgant, Charlotte Benson, Aisha B Miah, Thomas Powles, Ian Robert Judson and Khin Thway. Their work appears in journals such as Annals of Oncology, European Urology, European Urology Oncology, Clinical Cancer Research and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact